- Home
- » Tags
- » Zardaverine
Top View
- Study Protocol
- Large-Scale Transcriptional Profiling of Molecular Perturbations Reveals
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Phosphodiesterase (PDE)
- WO 2014/055801 Al 10 April 2014 (10.04.2014) P O P C T
- The Single Cyclic Nucleotide-Specific Phosphodiesterase of The
- (12) Patent Application Publication (10) Pub. No.: US 2013/0252924 A1 Penninger Et Al
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- FMO3 Inhibitors for Treating Pain
- Mitigation of NADPH Oxidase 2 Activity As a Strategy to Inhibit Peroxynitrite Formation
- Inotropic and Chronotropic Effects of Phosphodiesterase Inhibitors in The
- Systemic Therapy with Conventional and Novel Immunomodulatory Agents for Ocular Inflammatory Disease
- FIG. 8B (57) Abstract: the Methods and Compositions Described Herein Relate to the Treatment of Fungal Infections, E.G
- Cytotoxicity of Zardaverine in Embryonal Rhabdomyosarcoma from a Costello Syndrome Patient
- Implications of PDE4 Structure on Inhibitor Selectivity Across PDE Families
- New Drugs Review Thorax: First Published As 10.1136/Thx.46.7.512 on 1 July 1991
- WO 2009/011897 Al
- Known Bioactive Library: Tocriscreen Mini Library 2
- Literature Search Strategy for Treatment of Stable
- Human Neurogenesis Assay: Ramelteon
- (51) International Patent Classification: (74) Agent: HARRIS, Bob Et Al.; Viksnins Flarris Padys Malen A61K 31/4725 (2006.01) A6
- AN ACROLEIN-DERIVATIZED Camp ANTISERUM to STUDY Camp SIGNALING and VISUALIZATION in the ENTERIC NERVOUS SYSTEM-IMPLICATIONS for GUT INFLAMMATION
- Harmonized Tariff Schedule of the United States (2006) (Rev
- Neurogenesis Via Modulation of the Muscarinic Receptors
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Timothy Lewis,1 Luc De Waal,1 Xiaoyun Wu,1 Manuel Ellermann,2 Charlotte Kopitz,2 Antje Wengner,2 Knut
- Targeting Quorum Sensing
- Biomol ICCB Known Bi#123261
- An Alkaloid Initiates Phosphodiesterase
- Selective Phosphodiesterase Inhibitors for the Treatment of Bronchial Asthma and Chronic Obstructive Pulmonary Disease
- (12) United States Patent (10) Patent No.: US 7,985,756 B2 Barlow Et Al
- Cameron, Ryan T. (2014) the Role of Hsp20 in Alzheimer's Disease. Phd Thesis
- Role of Phosphodiesterase in the Biology and Pathology of Diabetes
- Universit Louis Pasteur Strasbourg
- Vanderbilt Evidence-Based Practice Center
- (12) Patent Application Publication (10) Pub. No.: US 2010/0022563 A1 Henkin (43) Pub